Kent Lake Capital’s Strata Skin Sciences SSKN Stock Holding History

Kent Lake Capital’s Portfolio SSKN Stock Details SSKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-165,804	Closed	-$2.49M	–	33
2020 Q4	$2.49M	Buy	+165,804	New	+$2.39M	1.18%	24

Other funds holding SSKN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kent Lake Capital's SSKN Position: Q1 2021 in Review

Kent Lake Capital sold out of Strata Skin Sciences (SSKN) in Q1 2021, closing a stake of 165,804 shares — an estimated $2.49M sold.

Kent Lake Capital first reported a position in SSKN in Q4 2020 and held it in 1 quarter. The position peaked at $2.49M in Q4 2020. 16 funds tracked by Wall St. Rank hold SSKN as of Q1 2021.

Kent Lake Capital reported no remaining Strata Skin Sciences position as of Q1 2021 after selling out during the quarter.
Kent Lake Capital sold 165,804 Strata Skin Sciences shares in Q1 2021, an estimated $2.49M.
Kent Lake Capital first reported a position in Strata Skin Sciences in Q4 2020 and held it in 1 quarter.
Kent Lake Capital's Strata Skin Sciences position peaked at $2.49M in Q4 2020.
16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2021.

Based on Kent Lake Capital's 13F filing for Q1 2021, filed 17 May 2021.